As of Feb 27
| +0.32 / +9.82%|
The 3 analysts offering 12-month price forecasts for Celldex Therapeutics Inc have a median target of 9.00, with a high estimate of 10.00 and a low estimate of 4.00. The median estimate represents a +151.40% increase from the last price of 3.58.
The current consensus among 3 polled investment analysts is to Buy stock in Celldex Therapeutics Inc. This rating has held steady since February, when it was upgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.